GB2250342A - Blood typing - Google Patents
Blood typing Download PDFInfo
- Publication number
- GB2250342A GB2250342A GB9025733A GB9025733A GB2250342A GB 2250342 A GB2250342 A GB 2250342A GB 9025733 A GB9025733 A GB 9025733A GB 9025733 A GB9025733 A GB 9025733A GB 2250342 A GB2250342 A GB 2250342A
- Authority
- GB
- United Kingdom
- Prior art keywords
- red blood
- filter
- blood cells
- areas
- wash fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
Abstract
A method and device for typing human blood groups is provided based on red blood cell agglutination. Reagents specific to various blood groups are placed into localized areas on a filter-type medium which is pervious to red blood cells. The blood to be typed is applied to each of the areas and the medium is subjected to a lateral flow of wash fluid. Red blood cells agglutinated by a specific reagent are retained in the medium producing a visually distinguishable area. When the red blood cells are not agglutinated, they are washed out of the medium with the wash fluid. Reagents are e.g. mono or polyclonal antibodies specific to blood groups of the ABO and Rhesus systems.
Description
A method and device for typing human blood groups
The present invention relates to a method and a device for typing human blood groups by determining the presence or absence of specific antigens and antibodies in a blood sample through antibody-antigen complex formation detected by red blood cell agglutination.
Human blood is classified into a number of systems of groups and various groups within these systems can be identified by the presence or absence of specific antigens. Under the ABO system red cell antigens and antibodies are specified in accordance with the following table.
Phenotype Genotype Antigens Naturally- Frequency
Occurring (UK)
Antibodies 0 00 0 Anti-A,B 46
A AA or AO A Anti-B 42
B BB or BO B Anti-A 9
AB AB AB None 3
In the Rhesus system, the red blood cells of the ABO blood groups most frequently found can be classified into those containing antigen D and those containing no antigen D (Rhesus positive versus Rhesus negative). when transfusing blood, knowing the blood group of the person donating blood and the person receiving the transfusion is of vital importance.
Conventional blood group typing involves visual or microscopic observation of the agglutination of red cells. Although reliable, agglutination reactions suffer from the disadvantages of subjective interpretation, the need for washed red blood cells and the need for refrigerated reagents and a centrifuge.
A dipstick for determining ABO blood groups is disclosed by Plapp et al. in 'The
Lancet", June 28, 1986, pages 1465-1466. The dipsticks are prepared by binding murine monoclonal anti-A or anti-B to nitrocellulose or nylon membranes. After applying whole blood to the surface of the membrane, unbound red cells are washed out by swirling the dipstick back and forth in a beaker of saline. This method has the disadvantage of requiring a separate beaker of saline solution and in addition the excessive washing caused by the swirling of the dipstick does not lead to reliable and easy to interpret results.
Other methods rely on the availability of a central laboratory with the appropriate facilities. It will be appreciated that many situations arise in medical treatment, in which the blood group of a patient must be known on site, however where no central laboratory is immediately available.
It is therefore the object of the present invention to provide a rapid and reliable method of determination of blood groups and an associated device, which can be employed on site only with the addition of a blood sample and which is also simple and inexpensive.
In accordance with the present invention a method and a device for typing blood groups are provided as defined in the claims. According to the present method, reagents, preferably antibodies specific to various blood groups are placed into localized areas on a thin section of a filter-type medium, preferably a fibrous material which is pervious to red blood cells. The blood to be typed is applied to each of the areas and the medium is then subjected to a lateral flow of wash fluid through the areas. Red-blood cells agglutinated by a specific reagent in a given area are retained in the medium producing a coloured area, thus indicating a positive result. When red blood cells are not agglutinated in a given area, the medium is such that the unagglutinated red blood cells are washed out with the wash fluid leaving an uncoloured region on the medium.This negative result is an indication that the antigen for a specific blood group was not present on the red blood cells.
To be operable, the medium employed in the method must be pervious to red blood cells in the unagglutinated state, i.e. under application of the wash fluid the red blood cells can laterally migrate away from the localized areas when no antibody-antigen complex formation has taken place.
In a preferred embodiment, the medium comprises fibrous hydrophilic material, in particular polyethylene fibers which have been made hydrophilic through suitable treatment. Preferably the fibers are formed from a composition of LLDPE (linear low-density polyethylene) and a wetting agent. The most preferred LLDPE is an ethylene/octene copolymer as described in US 4 578 414.
The device according to the present invention comprises a piece of filter-type material, preferably fibrous material having a plurality of localized areas arranged therein, where the areas contain reagents specific to various blood groups and wherein the material is substantially pervious to red blood cells and substantially impervious to agglutinated red blood cells. The material is also pervious to a wash fluid which is capable of washing essentially all unagglutinated red blood cells out of a respective area.
In one preferred embodiment of the device, the filter-type material is a fibrous hydrophilic material located on a non-absorbent or hydrophobic support means.
The fibrous material and support means are enclosed in a housing. The housing is provided with openings to expose the areas containing reagents, thus allowing the application of the blood to be typed. In a further embodiment, the piece of fibrous material is provided as an elongated strip. The device is also provided with supply means on a first end for introducing the wash solution and absorbing means on the other end of the strip for enhancing the flow or wicking of wash solution across the medium. The agglutination results according to the present invention can be readily read by visual inspection. The positive results indicated by coloured spots in the localized area for a particular blood group are highly distinguishable over the areas where no complex formation has taken place and the red blood cells have been washed out.
The blood group test can be completed within about 3 minutes, so that the result is not only easy to read but is also readily available. The device can be handheld and in one embodiment is provided with prestored wash fluid. It then forms a self-contained unit which only requires the application of a blood sample.
The blood to be typed can be fresh blood used immediately prior to clotting, blood preserved using heparin or SAG-M. The blood need not be centrifuged or pretreated prior to testing.
The device has the further advantage that it is enclosed in a housing in a manner which minimizes exposure to the blood by the user. After the test, the device can be- disposed of with minimal hazard and potentially no human contact of the blood.
Further details of the invention will become apparent in the following description of embodiments by way of reference to the drawings.
Figure 1 shows a schematic diagram representing the basic principles of the
present invention.
Figure 2 shows an embodiment employing a circular piece of fibrous material
in a device according to the present invention.
Figure 3 shows a further embodiment of the device according to the present
invention.
Figure 4 shows examples of blood typing tests obtained according to the
present invention.
The invention is broadly applicable to the use of blood typing reagents, in particular antibodies specific to the antigens on red blood cells of human blood.
In the embodiment of Fig. 1, the antibodies anti-A, anti-AB and anti-B are placed in the localized areas or zones la, 1b and 1c. The areas can have any shape, a circular or dot-shape is preferred. An anti-Rhesus D-positive antibody is placed in the area ld in Fig. 1 while the area le contains a non-specific binding agent for red blood cells as a control. Any suitable combination or sequence of antibodies can be used as will be discussed further below.
The employed antibodies can be monoclonal or polyclonal antibodies specific to the blood groups of the ABO and Rhesus systems. Preferred antibodies are murine monoclonal or polyclonal antibodies for example obtainable from Lorne Laboratories Ltd., Great Britain.
The antibodies are spot loaded in liquid form to the medium 10 of Fig. 1. Any suitable means can be employed for applying the antibodies, for example by hand or using a thin layer chromatography applicator. For each localized zone la-ld a volume of 1 to 10 pl of antibody is applied. Preferrably the antibody is applied in an amount of 2 to 5 pl for each localized zone. In one embodiment, a binding agent for all red blood cells is provided at one end of the medium 10 namely in the zone le. The binding agent can be applied in an amount of 1 to 10 fil.
Preferred agents are gluteraldehyde and lectins.
After application of the antibodies and optionally a binding agent, the medium is dried by heating for 30 minutes to 2 hours at a temperature in the range of 30"C to 60or. For this purpose, the medium can be placed on a non-absorbent surface in order that antibody not be extracted from the medium. It has been found that particularly good results are obtained when heating is carried out in the preferred range of 30 minutes to 1 hour in a temperature range of 30"C to 40"C.
The result of this heating is that the antibodies are dried onto or deposited upon the filter type material. surface. This can be the outer and/or inner surface, preferably the outer and inner surfaces of the material.
The filter type material can also be provided with a backing. The backing if employed should be non-absorbent, preferably of a plastic material which can be bound to the filter-type material. Possible methods of binding include adhesive bonding, heat or ultrasonic welding (continuous or intermittent) or casting or forming the material directly onto a backing. Most preferably, the filter-type material is a hydrophilic fibrous material with a backing of a hydrophobic media such as polytetrafluoroethylene (VISE) or polyvinylidene fluoride (PVDF) as well as nonporous films such as polyolefin sheet or fibrous web.
The material 10 according to the present invention is a filter-type material capable of being loaded with antibodies as described above. The dried-on antibodies are retained by the material when kept under dry conditions. The material has the further property that it is permeable to red blood cells, i.e. the pore size in the medium is such that red blood cells are not retained to a significant extent and also do not bind to the fibrous material. On the other hand, agglutinated red blood cell complexes are retained by the material, i.e. cannot to a significant extent migrate through the material.
The material in a particular embodiment can be a polyolefin,
preferably polyethylene, polypropylene or an ethylene-lower olefin
copolymer. LLDPE (linear low density polyethylene) is most
preferred. Generally suitable polymers include those of olefins of
2 to 10 C atoms. More preferred is a copolymer of ethylene and
0.5 to 8 weight % of a comoncmer, more preferably 1 to 7 weight %.
Preferred comonomers are olefins with 4 to 10 C atoms, most
preferably 4 to 8 C atoms, most preferred is a copolymer of
ethylene and 1-octene.
When polyethylene is used, it is made water wettable or hydrophilic by the addition of a suitable amount of a wetting or surface active agent. Wetting agents can include a) an alkoxylated alkyl phenol along with a mixed mono-, di- and/or triglyceride
or b) a polyoxyalkylene fatty acid ester or c) a combination of (b) and any part of (a).
Such wetting agents are described in US 4,578,414. The alkoxylated alkyl phenol is preferably one where the alkyl group has 1 to 20 carbon atoms, most preferably about 6 to about 12 carbon atoms. A polyethoxy chain is the preferred polyalkoxy chain. The mixed glyceride is preferably a glyceride of a fatty acid. The fatty acid may be saturated or unsaturated and is preferably a mixture of fatty acids having a carbon chain length in the range of about 12 to about 18 carbon atoms.
Particularly preferred wetting agents include Atmer 645, a complex mixed glyceride with a long chain fatty acid adduct, available from ICI America Inc. Another wetting agent is a monoester of Z-9-octadecenoic acid and 1, 2, 3 -propanetriol, available from Dow Chemical as XU 61518.10.
The above described substances can be processed to form the filter type material of the present invention by any suitable method. The preferred fibrous hydrophilic material can be made for example from fibers, preferably from spun fiber, particularly from melt spun fibers. The most preferred form of the present material is one produced by melt blowing the above mentioned preferred ethylene copolymer combined with a wetting agent.
The formed fibrous material can be in the form of a web or mat and can be calendered. Uncalendered material has been found more effective however and is preferred.
The preferred fibrous hydrophilic material according to the present invention has one or more of the following properties in combination in the following broad or preferred ranges.
Property broad range preferred range
Wetting agent content (% by weight) in the polyethylene composition 0.5 - 5.0 0.6 - 3.0
particularly about 1.0
Fiber diameter (pm) 1.0 - 15 2 - 11
CWST of the melt blown fiber (dynes/cm) 30 - 120 100 - 120
Pore size of the fiber material (microns) (ASTM F 316-80) 3 - 300 5 - 20
Retained water volume/
Volume of material (cm3 water/cm3 material) 0.6 - 0.95 0.7 - 0.9
particularly about 0.85
Material weight (g/ft2) 2 - 8 3 - 4
Treatment (calendered or uncalendered) - uncalendered
preferred
Thickness (cm) 0.01 - 0.07 0.02 - 0.06
particularly about 0.03
For the purposes of the embodiments in figures 1 and 2, the material is provided in elongated strips, for example 6 cm long and 1 cm wide.
Having prepared a strip 10 of the fibrous hydrophilic material as shown in Fig.
1, an amount of the blood to be typed is applied to each of the localized zones 1, preferably about one drop of blood or approximately 5 to 10 sLl. The reaction of the antibodies in the medium with the added blood is immediate and there is no need to allow a longer time for complex formation before proceeding to the washing step. On the other hand, it has been found that the blood can be left on the spots or zones up to 6 minutes before introducing the wash solution. This did not impair the test results.
A wash fluid or solution is then introduced into the medium, for example at a first end 10a as shown in the embodiment of Fig. 1. The solution can be introduced by any suitable means. Figure 1 shows a feed pad 16 which for example could be preloaded with wash solution and squeezed to emit the solution.
For the above mentioned embodiment with a strip size of 6 by 1 cm, it has been found that a volume of about 0.5 ml of wash solution is optimal. Suitable wash solutions include phosphate-buffered saline (PBS), physiological saline or deionized water.
After introducing the wash solution, it wicks along the strip 10 in the flow direction indicated with the arrow Z under capillary action. The solution is left to wick along the medium carrying with it unagglutinated blood cells. The solution and cells migrate to the opposite end of the strip shown in Fig. 1 as the second end 10b. In a preferred embodiment, an absorbent pad 20 is provided in contact with the second end of the strip, thereby enhancing the wicking action. According to Fig. 1, the wash solution flows in a longitudinal direction and sequentially through the respective zones 1. The invention however is not limited to this configuration. The wash solution could for example be introduced to flow laterally with respect to the strip indicated in Fig. 1.It is also possible that the piece of fibrous material used as the medium be provided in a round, oval, square or any other shape with any appropriate configuration of the zones containing antibody.
Good results have been found according to the present invention, where the reagent-loaded areas have a diameter of about 0.2 to about 0.8 cm, preferably 0.25 to 0.5 cm. The lateral or longitudinal flow of wash solution then guarantees a clearly distinguishable positive or negative result. It is therefore preferred to provide the flow of wash solution in the plane of the material, whether this be longitudinally, transversely or for example radially when the medium is provided in a round shape.
A second embodiment employing a circular piece of the fibrous material is shown in Fig. 2. The wash fluid is introduced by means of the feed pad 76 and flows outwardly through the antibody containing zones. In this embodiment, an absorbent pad 70 is provided about the circumference of the fibrous material 10, again having the function of enhancing migration through the material.
The purpose of the wash solution is to remove red blood cells from those zones or areas where the red blood cells have not been agglutinated by the associated antibody. As mentioned above, the medium is pervious to red blood cells and they migrate out of a given zone where antibody-antigen complex formation has not taken place and leave behind an uncoloured region, i.e. the color of the area returns substantially to its initial color.
A zone in which agglutination has taken place retains a coloured spot, normally red, and indicates a positive result. Antibody-antigen reactions have produced an agglutination complex which is retained in the medium. The formed complexes in the medium are retained in the pores and cannot migrate through the medium with the wash solution.
Having carried out the test which generally will require approximately 3 minutes, the blood group type can be read according to the presence or absence of red spots. For example with the antibodies employed in the embodiment of figure 1, a positive reaction for the zones A and AB and a negative result for the zones
B and Rh+ would indicate the blood group A-. The blood group O- for example would be indicated by no reaction in any of the zones A, AB, B or Rh+. This example demonstrates the purpose of the red cell binding agent 22 in the zone le. For the group 0- all red blood cells wash out of the regions containing anti
B, anti-AB, anti-B and Rh + leaving uncoloured zones.The presence of a red spot in the zone le for the binding agent is a control for the fact that red blood cells have indeed passed through the previously mentioned zones and reached the second end 10b of the medium in Fig. 1. Thus they migrate from the zones la to ld and are captured at le by the binding agent 22.
An embodiment of the device according to the present invention is illustrated in
Fig. 3. The device comprises a piece of fibrous material 10 mounted on a nonabsorbent substrate layer 12. Alternatively the fibrous material 10 can be provided with a non-absorbent backing which would relinquish the need for a substrate layer. Such a backing for example can be a hydrophobic resin, preferably a hydrophobic polyolefin layer bonded to the fibrous material. The fibrous material 10 and support means 12 are enclosed in a housing 14 which preferably consists of a svnthetic material such as plastic. The support means 12 can either be a separate material or preferably part of the plastic housing.In the embodiment of
Fig. 3, the antibody containing zones on the piece of fibrous material are located adjacently along a longitudinal axis of said material where the piece of fibrous material is preferably an elongated strip. The housing comprises a plurality of openings or wells 2 which expose the antibody containing zones and allow application of the blood to be typed.
The device of the present invention is also provided with supply means 16, 17 and 18 for introducing wash solution to a first end 10a of the fibrous material. In one embodiment, the supply means comprise a feed pad 16 in contact with the end 10a of the fibrous material where the feed pad 16 has an exposed portion 16a into which the wash solution can be supplied. This can be accomplished for example by manually applying the wash solution in the appropriate amount to the exposed end portion. According to Fig. 3, the supply means can also be comprised of a bulb 18 containing the wash solution, where a breakable seal connects the contents of the bulb through a passage 17 to the feed pad 16.
Exerting pressure on the bulb 18 breaks the seal 19 and allow a flow of wash solution to the pad 16 and subsequently through the strip of fibrous material 10.
The device according to the invention is also provided with absorbing means 20 arranged in contact with the second end 10b of the strip of fibrous material. As mentioned above, the absorption of the wash solution at the end of the strip promotes flow by wicking to said second end and therefore through the antibody containing zones. The absorbing means 20 are preferably completely enclosed in the housing which reduces the possibility of blood contact with the user of the device during and after the test.
The wells 2 or windows are also arranged as recesses which will also prevent direct contact with the blood being typed. The results of the test can be easily read by observing the presence or absence of read spots in the respective windows.
The performance of the method is illustrated by the following example.
Example
This example illustrates the present method for testing the blood groups B-, B+ and 0 + under various conditions. In a first run, 2 pl of the antibody anti-A, anti
AB and anti-B and anti-Rh +, were applied to a fibrous hydrophilic polyethylene medium. The fibrous material was prepared from a copolymer of 94 weight ao ethylene and 6 weight 5i octene-l, a copolymer available commercially from Dow
Chemical Company as Aspun 6809. To this copolymer was added 1 weight-5to of a monoester of Z-9-octedecenoic acid and 1, 2, 3 - propanetriol as the wetting agent. The mixture was blended in a Banbury mixer for 30 minutes. The mixture was then turned into a homogenous blend by passage through an extruder at a temperature just above the melting point of the thermoplastic polymer at about 205"C. The extrudate was then cooled and chopped into pellets. The pellets were then heated to 610 F (231"C) and fiberized by passing through a melt blowing die at 150 psi resin pressure and 20 psi air pressure. The emerging fibers were collected to form a fibrous web of 4 g/ft2 for use as the medium. The antibody was soaked into the medium and was dried in an oven for 30 minutes at 37"C.
Three such strips of material 6 by 1 cm were prepared for testing the three blood groups B-, B+ and 0+. Same-day blood in an amount of 2 ,ul was applied to each antibody containing zone. After applying the blood, the material was immediately wicked with 0.5 ml of phosphate-buffered saline. The results are given in Fig. 4. The presence of the blood group B+ is indicated by the (red) spots at the zones B and AB, while the Rhesus factor Rh+ is indicated by the (red) spot at the zone for the Rh+ antibody. The B-test shows coloration in the zones
B and AB, with no reaction in the Rh zone. The blood group 0+ shows a dear, colorless region in the zones for the antibodies A, AB and B and a mark indicating the Rh+ factor.
Gluteraldehyde was used as a positive control in an additional zone. The positive control can be seen by the (red) spots at the top of the strips along the flow direction Z.
Claims (29)
1. A method for typing blood groups comprising
a) adding an amount of blood to a plurality of areas of a thin section
of a filter-type material,
aa) wherein different reagents which are capable of agglutinating red
blood cells in a way specific to the blood type are located in
individual areas of the material,
bb) wherein said filter type material is substantially pervious to red blood
cells and substantially impervious to agglutinated red blood cells, and
is pervious to a wash fluid which is capable of washing essentially
all non-agglutinated red blood cells out of a respective area,
b) passing through said section such a wash fluid in a direction
substantially orthogonal to the thickness dimension of said section and
removing substantially all non-agglutinated red blood cells out of the
respective areas while leaving significant amounts of agglutinated red
blood cells in other respective areas, thereby producing coloured and
uncoloured areas on said section.
2. Method of claim 1, characterized in that said filter-type material has a further
area having a non-specific binding agent for red blood cells located therein,
in particular wherein said binding agent is selected from gluteraldehyde and
lectin.
3. Method of claim 1 or 2, characterized in that said reagents are antibodies
specific to the antigens of the blood groups of the ABO and Rhesus systems,
in particular wherein said reagents are murine monoclonal or polyclonal
antibodies.
4. Method of claim 3, characterized in that antibodies specific to the antigens
of the ABO blood groups A, AB and B and the Rhesus group D positive
are located in said areas of the filter-type material.
5 Method of one of the preceding claims, characterized in that said wash fluid
is selected from the group of phosphate-buffered saline, physiological saline
and deionized water.
6. Method of one of the preceding claims, characterized in that said filter-type
material comprises fibrous hydrophilic material.
7. Method of claim 6, characterized in that said fibrous hydrophilic material is
polyethylene fiber containing a wetting agent.
8. Method of claim 6 or 7, characterized in that said fibrous hydrophilic material
has a pore size of about 5 to about 20 microns, and a ratio of retained
water volume to volume of material of about 0.7 to about 0.9 cm3 water/cm3
material.
9. Method of one of the preceding claims, characterized in that said filter-type
material is provided as an elongated strip with said areas arranged along a
longitudinal axis thereof.
10. Method of claim 9, characterized in that said wash fluid is introduced at a
first end of said elongated strip and flows longitudinally through each of said
areas to a second end of said elongated strip, said wash fluid transporting
with it non-agglutinated red blood cells.
11. Method of claim 9 or 10, characterized in that said non-specific binding agent
is located in the wash flow direction from said first strip end to said second
strip end following said antibody-containing zones but before said second end.
12. Method of claim 9 to 13, characterized in that an absorbent pad is provided
at said second end of said elongated strip to enhance the flow of wash fluid
and non-agglutinated red blood cells in the direction of the second end.
13. Method of preparing a filter-type material for use in the blood typing method
of the claims I to 12, characterized in that blood-group specific antibodies are
attached to localized areas on said material by applying a volume of antibody
in the range of 1 to 10 pl to the respective areas and heating for 30 min.
to 2 hours at a temperature in the range of 30"C to 60aC.
14. Method of claim 13, characterized in that a volume in the range of 2 to 5 ,ul of antibody is applied to said localized zones.
15. Method of claim 13 or 14, characterized in that said heating is carried out
for 30 min. to 1 hour at a temperature in the range of 30"C to 40"C.
16. Method of any of the claims 13 to 15, characterized in that said filter-type
material comprises fibrous hydrophilic material.
17. Method of claim 16, characterized in that said fibrous hydrophilic material is
polyethylene fiber containing a wetting agent, in particular wherein said wetting
agent is selected form the group of
a) an alkoxylated alkyl phenol along with a mixed mono-, di- and/or tri
glyceride or
b) a polyoxyalkylene fatty acid ester or
c) a combination of (b) and any part of (a).
18. Method of claims 16 or 17, characterized in that said fibrous hydrophilic
material has a pore size of about 5 to 20 microns and a ratio of retained
water volume to volume of material of about 0.7 to about 0.9 cm3 water/cm3
material.
19. Device for typing blood groups comprising a piece (10) of filter-type,
preferably fibrous material having a plurality of localized areas (1) arranged
therein, said areas containing reagents specific to various blood groups,
wherein said material is substantially pervious to red blood cells and
substantially impervious to agglutinated red blood cells, and is pervious to a
wash fluid which is capable of washing essentially all non-agglutinated red
blood cells out of a respective area.
20. Device of claim 19, further characterized by
a) a housing (14) enclosing said piece of filter-type material and a
nonabsorbent support means (12) upon which said piece is located, said
housing having openings (2) to expose said reagent containing areas, to
allow application of the blood to be typed,
b) supply means (16, 17, 18) for introducing a wash fluid to a first end
(10a) of said piece of filter-type material, said supply means having an
exposed portion (16a) in said housing,
(c) absorbing means (20) enclosed within said housing and in contact with
a second end (lOb) of said piece of filter-type material to enhance the
flow of said wash fluid.
21. Device of claim 19 or 20, characterized in that said piece (10) of filter-type
material comprises a further localized area (le) containing a non-specific
binding agent for red blood cells and an opening (2e) in said housing to
expose said further localized area.
22. Device of claim 19 or 21, characterized in that said reagents are antibodies
specific to the antigens of the blood groups of the ABO and Rhesus systems,
in particular wherein said reagents are murine monoclonal or polyclonal
antibodies.
23. Device of claim 22, characterized in that localized areas (1) are provided for
antibodies specific to the antigens of the blood groups A, AB and B and the
Rhesus group D positive.
24. Device of any of the claims 19 to 23, characterized in that said piece of
filter-type material is an elongated strip (10) of fibrous hydrophilic material
having a thickness of 1 to 4 mm.
25. Device of claim 24, characterized in that said fibrous hydrophilic material
comprises polyethylene fiber containing a wetting agent, in particular wherein
said wetting agent is selected from the group of
a) an alkoxylated alkvl phenol along with a mixed mono-, di- and/or tri
glyceride or
b) a polyoxyalkylene fatty acid ester or
c) a combination of (b) and any part of (a).
26. Device of claim 25, characterized in that said fibrous material has a pore size
of 5 to 20 microns and a ratio of retained water volume to volume of
material of about 0.7 to about 0.9 cm3 water/cm3 material.
27. Device of any of the claims 24 to 26, characterized in that said absorbing
means (20) comprise an absorbent pad in overlapping contact with said second
end (lOb) of the elongated strip.
28. Device of any of the claims 24 to 27, characterized in that said supply means
comprise a feed pad (16) with an exposed end (16a), which is arranged so
that the feed pad can be externally wetted at the exposed end to supply a
wash fluid to the first end (10a) of the elongated strip.
29. Device of any of the claims 24 to 27, characterized in that supply means
comprise a feed pad (16) and a bulb (18) containing said wash fluid, where
one wall of said bulb (18) is provided with a breakable seal (19), which when
broken allows communication of said wash fluid to said feed pad (16).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9025733A GB2250342B (en) | 1990-11-27 | 1990-11-27 | A method and device for typing human blood groups |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9025733A GB2250342B (en) | 1990-11-27 | 1990-11-27 | A method and device for typing human blood groups |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9025733D0 GB9025733D0 (en) | 1991-01-09 |
GB2250342A true GB2250342A (en) | 1992-06-03 |
GB2250342B GB2250342B (en) | 1995-04-12 |
Family
ID=10686031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9025733A Expired - Fee Related GB2250342B (en) | 1990-11-27 | 1990-11-27 | A method and device for typing human blood groups |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2250342B (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995030904A1 (en) * | 1994-05-10 | 1995-11-16 | Stichting Centraal Laboratorium Van De Bloedtransfusiedienst Van Het Nederlandse Rode Kruis | Solid-phase filtration method for antigen and antibody assays in bloodgroup serology, and test kit |
WO2005005991A1 (en) * | 2003-07-09 | 2005-01-20 | Medion Diagnostics Gmbh | Device and method for simultaneously identifying blood group antigens |
WO2005073733A1 (en) * | 2002-11-06 | 2005-08-11 | Eduardo Cadorniga Martinez | Self-performed abo blood group determination method |
WO2006051548A2 (en) * | 2004-11-15 | 2006-05-18 | Inverness Medical Switzerland Gmbh | Blood type method system and device |
NL1027737C2 (en) * | 2004-12-14 | 2006-06-16 | Teststrip B V | Chromatographic analysis device and test kit. |
CN101603967A (en) * | 2008-06-10 | 2009-12-16 | 英科新创(厦门)科技有限公司 | The method and the kit of fast detecting people ABO/Rh/MN blood group |
US20100184102A1 (en) * | 2007-07-02 | 2010-07-22 | Abo Diag, Societe Par Actions Simplifiee | Device and method for identifying and determining blood groups |
CN103336122A (en) * | 2013-06-24 | 2013-10-02 | 中国科学院苏州生物医学工程技术研究所 | Immunofluorescence chromatography test strip for detecting platelet antibody and detection method of platelet antibody |
CN103502819A (en) * | 2011-04-21 | 2014-01-08 | 西门子公司 | Blood typing devices and methods for testing blood type |
CN103765221A (en) * | 2011-05-26 | 2014-04-30 | 西门子公司 | Blood typing system |
WO2015071597A2 (en) | 2013-11-14 | 2015-05-21 | bioMérieux | Novel filter medium for obtaining plasma, and associated filtration device and method |
CN104714034A (en) * | 2013-12-17 | 2015-06-17 | 天津德祥生物技术有限公司 | Blood type detection method based on membrane structure |
CN104950114A (en) * | 2014-03-31 | 2015-09-30 | 天津德祥生物技术有限公司 | Screening method for serum (plasma) antibody based on membrane structure and preparation method of screening and detecting kit |
CN104950115A (en) * | 2014-03-31 | 2015-09-30 | 天津德祥生物技术有限公司 | Reverse typing detecting method for human ABO blood type based on membrane structure |
CN106771267A (en) * | 2016-12-29 | 2017-05-31 | 武汉伽诺美科技有限公司 | A kind of quick blood typing detection card |
US10328193B2 (en) | 2012-03-21 | 2019-06-25 | Gambro Lundia Ab | Extracorporeal blood treatment apparatus with multiple treatment solution reservoirs |
WO2021175239A1 (en) * | 2020-03-04 | 2021-09-10 | 重庆大学 | Automatic multi-blood-group system test card and test method |
CN116087534A (en) * | 2022-12-30 | 2023-05-09 | 天津德祥生物技术股份有限公司 | Erythrocyte antigen detection method and detection kit |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0223978A1 (en) * | 1985-10-11 | 1987-06-03 | Abbott Laboratories | Diagnostic test |
-
1990
- 1990-11-27 GB GB9025733A patent/GB2250342B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0223978A1 (en) * | 1985-10-11 | 1987-06-03 | Abbott Laboratories | Diagnostic test |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995030904A1 (en) * | 1994-05-10 | 1995-11-16 | Stichting Centraal Laboratorium Van De Bloedtransfusiedienst Van Het Nederlandse Rode Kruis | Solid-phase filtration method for antigen and antibody assays in bloodgroup serology, and test kit |
NL9400777A (en) * | 1994-05-10 | 1995-12-01 | Stichting Centraal Lab | Solid phase filtration method for antigen and antibody determinations in blood group serology, and test kit. |
WO2005073733A1 (en) * | 2002-11-06 | 2005-08-11 | Eduardo Cadorniga Martinez | Self-performed abo blood group determination method |
WO2005005991A1 (en) * | 2003-07-09 | 2005-01-20 | Medion Diagnostics Gmbh | Device and method for simultaneously identifying blood group antigens |
KR101214620B1 (en) | 2003-07-09 | 2012-12-21 | 메디온 디아그노스틱스 아게 | Device and method for simultaneously identifying blood group antigens |
US8053226B2 (en) | 2003-07-09 | 2011-11-08 | Medion Diagnostics Ag | Device and method for simultaneously identifying blood group antigens |
CN1816746B (en) * | 2003-07-09 | 2010-05-05 | 麦迪奥诊断产品股份公司 | Device and method for simultaneously identifying blood group antigens |
WO2006051548A3 (en) * | 2004-11-15 | 2007-05-24 | Inverness Medical Switzerland | Blood type method system and device |
WO2006051548A2 (en) * | 2004-11-15 | 2006-05-18 | Inverness Medical Switzerland Gmbh | Blood type method system and device |
NL1027737C2 (en) * | 2004-12-14 | 2006-06-16 | Teststrip B V | Chromatographic analysis device and test kit. |
WO2006065118A2 (en) * | 2004-12-14 | 2006-06-22 | Teststrip B.V. | Chromatographic analyse-devices and test kits |
WO2006065118A3 (en) * | 2004-12-14 | 2007-03-22 | Teststrip B V | Chromatographic analyse-devices and test kits |
EP2942626A1 (en) * | 2007-07-02 | 2015-11-11 | Abo Diag | Device and method for identifying and determining blood groups |
US20100184102A1 (en) * | 2007-07-02 | 2010-07-22 | Abo Diag, Societe Par Actions Simplifiee | Device and method for identifying and determining blood groups |
US8546084B2 (en) * | 2007-07-02 | 2013-10-01 | Abo Diag | Device and method for identifying and determining blood groups |
EP2315024A4 (en) * | 2008-06-10 | 2011-07-13 | Intec Products Inc Xiamen | A method of quickly determining human abo/rh/mn blood type and a test kit thereof |
CN101603967A (en) * | 2008-06-10 | 2009-12-16 | 英科新创(厦门)科技有限公司 | The method and the kit of fast detecting people ABO/Rh/MN blood group |
US20110076698A1 (en) * | 2008-06-10 | 2011-03-31 | Intec Products, Inc. (Xiamen) | method of quickly determining human abo/rh/mn blood type and a test kit thereof |
CN101603967B (en) * | 2008-06-10 | 2015-02-18 | 英科新创(厦门)科技有限公司 | Method for fast testing human ABO/Rh/MN blood type and kit |
EP2315024A1 (en) * | 2008-06-10 | 2011-04-27 | Intec Products, Inc. (Xiamen) | A method of quickly determining human abo/rh/mn blood type and a test kit thereof |
CN103502819A (en) * | 2011-04-21 | 2014-01-08 | 西门子公司 | Blood typing devices and methods for testing blood type |
CN103765221A (en) * | 2011-05-26 | 2014-04-30 | 西门子公司 | Blood typing system |
CN103765221B (en) * | 2011-05-26 | 2015-12-09 | 西门子公司 | Blood group determination system |
US10328193B2 (en) | 2012-03-21 | 2019-06-25 | Gambro Lundia Ab | Extracorporeal blood treatment apparatus with multiple treatment solution reservoirs |
CN103336122B (en) * | 2013-06-24 | 2016-01-20 | 中国科学院苏州生物医学工程技术研究所 | The immunofluorescence chromatograph test strip that a kind of platelet antibody detects and detection method |
CN103336122A (en) * | 2013-06-24 | 2013-10-02 | 中国科学院苏州生物医学工程技术研究所 | Immunofluorescence chromatography test strip for detecting platelet antibody and detection method of platelet antibody |
WO2015071597A2 (en) | 2013-11-14 | 2015-05-21 | bioMérieux | Novel filter medium for obtaining plasma, and associated filtration device and method |
US10398825B2 (en) | 2013-11-14 | 2019-09-03 | Biomerieux | Filter medium for obtaining plasma, and associated filtration device and method |
US11040130B2 (en) | 2013-11-14 | 2021-06-22 | Biomerieux | Filter medium for obtaining plasma, and associated filtration device and method |
CN104714034A (en) * | 2013-12-17 | 2015-06-17 | 天津德祥生物技术有限公司 | Blood type detection method based on membrane structure |
CN104950115A (en) * | 2014-03-31 | 2015-09-30 | 天津德祥生物技术有限公司 | Reverse typing detecting method for human ABO blood type based on membrane structure |
CN104950114A (en) * | 2014-03-31 | 2015-09-30 | 天津德祥生物技术有限公司 | Screening method for serum (plasma) antibody based on membrane structure and preparation method of screening and detecting kit |
CN106771267A (en) * | 2016-12-29 | 2017-05-31 | 武汉伽诺美科技有限公司 | A kind of quick blood typing detection card |
WO2021175239A1 (en) * | 2020-03-04 | 2021-09-10 | 重庆大学 | Automatic multi-blood-group system test card and test method |
CN116087534A (en) * | 2022-12-30 | 2023-05-09 | 天津德祥生物技术股份有限公司 | Erythrocyte antigen detection method and detection kit |
Also Published As
Publication number | Publication date |
---|---|
GB2250342B (en) | 1995-04-12 |
GB9025733D0 (en) | 1991-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2250342A (en) | Blood typing | |
US4797259A (en) | Well-type diagnostic plate device | |
US5064541A (en) | Devices and methods for the collection of a predetermined volume of plasma or serum | |
US4477575A (en) | Process and composition for separating plasma or serum from whole blood | |
EP0392377B1 (en) | Method and device for the separation of plasma or serum from whole blood | |
US4256693A (en) | Multilayered integral chemical analysis element for the blood | |
US5846438A (en) | Fibrous web for processing a fluid | |
US5082626A (en) | Wedge shaped test strip system useful in analyzing test samples, such as whole blood | |
US5411858A (en) | Manufacturing process for sample initiated assay device | |
US8097171B2 (en) | Method of separating a fluid fraction from whole blood | |
JPH0453262B2 (en) | ||
JPH0547780B2 (en) | ||
US4340565A (en) | Hematocrit value determining element | |
JPH0614037B2 (en) | Chemical test equipment and method | |
EP0239174B1 (en) | Biological diagnostic device | |
WO2001024931A1 (en) | Capillary device for separating undesired components from a liquid sample and related method | |
JP3560934B2 (en) | Method and apparatus for separating plasma or serum from whole blood | |
EP0435298A2 (en) | Device and method for blood separation | |
JPH0526875A (en) | One-piece type multilayer analysis element | |
JP3147560B2 (en) | Multi-item analysis method | |
JPH0526876A (en) | Dry process analysis element for analyzing whole blood sample | |
GB2262986A (en) | Particle agglutination assay | |
JPH0341362A (en) | Diagnostic instrument having plurality of porous absorptive element | |
JPH0735747A (en) | Manufacture of dry analytic element for measuring multiple items | |
GB2236123A (en) | Diagnostic device with porous, absorbent fabric |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19991127 |